Talk Presenting Companies (Theatre B) track
Autoimmune/Inflammation: Henan EMICRO Biomedicine Co., Ltd.
Mon, Nov 9, 2026 · 9:45–10:00 AM CET Koelnmesse
About this session
EMICRO Biomedicine is a biotech company focused on the R & D, production, and commercialization of First in Class innovative drugs for the treatment of autoimmune diseases and oncology. Since its inception in 2016, the company has been committed to addressing unmet clinical needs through solid research and relentless innovation. EMICRO has established a balanced and diversified pipeline that strategically combines candidates targeting validated pathways with those against novel targets.
Speaker
-
CBO · Henan EMICRO Biomedicine Co., Ltd.
Speaker